Thomas Ebensen
9Patents
2h-index
9Co-inventors
40Inventor score
Filing activity: Oct 19, 2006 → Jan 19, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9597391B2 | Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositions | Emerging Cross-Sectional Technologies | 21 | Active |
| US8119689B2 | Adjuvants on the basis of bisacyloxypropylcystene conjugates and derivatives and their uses in pharmaceutical compositions | Human Necessities | 6 | Active |
| US8053417B2 | Hexosylceramides as adjuvants and their uses in pharmaceutical compositions | Emerging Cross-Sectional Technologies | 1 | Active |
| US8257734B2 | PQS and its conjugates as adjuvants and their uses in pharmaceutical compositions | Emerging Cross-Sectional Technologies | 1 | Active |
| US8211463B2 | Use of glycolipids as adjuvants | Human Necessities | 0 | Active |
| US11576968B2 | Hepatitis C virus immunogenic compositions and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US10881726B2 | Hepatitis C virus immunogenic compositions and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US10918733B2 | Lipopeptide- and lipoprotein-conjugates and its use | Human Necessities | 0 | Active |
| US12042536B2 | Hepatitis C virus immunogenic compositions and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.